MM MBRACE THERAPEUTICS

Live / Allowed — Fourth extension granted (statement of use) (as of 08 Sept 2026)

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 26 Jan 2024 filing date already counts against anyone who files later.

Record

Serial number
98378002
Mark type
Design + words
Filed
26 Jan 2024
Published for opposition
01 Oct 2024
Attorney of record
Rebeccah Gan

Goods and services

  • Class 005 — Pharmaceuticals: Antibody drug conjugate being medicines which deliver chemotherapy agents to kill cancer cells and/or abort cell multiplication; Tumor suppressing agents; Pharmaceutical preparations for suppressing tumors
  • Class 044 — Medical, beauty and agricultural services: Antibody testing for medical diagnostic or treatment purposes

Owner

Prosecution history

  • 09 Sept 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 08 Sept 2026 — SOU EXTENSION 4 GRANTED
  • 08 Sept 2026 — SOU EXTENSION 4 FILED
  • 08 Sept 2026 — SOU TEAS EXTENSION RECEIVED
  • 03 Apr 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 02 Apr 2026 — SOU EXTENSION 3 GRANTED
  • 02 Apr 2026 — SOU EXTENSION 3 FILED
  • 02 Apr 2026 — SOU TEAS EXTENSION RECEIVED
  • 13 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 13 Nov 2025 — SOU EXTENSION 2 GRANTED
  • 12 Nov 2025 — SOU EXTENSION 2 FILED
  • 12 Nov 2025 — SOU TEAS EXTENSION RECEIVED
  • 10 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 09 May 2025 — SOU EXTENSION 1 GRANTED
  • 09 May 2025 — SOU EXTENSION 1 FILED

View this trademark record on Rightsy